A BILL 
To amend the Orphan Drug Act to reauthorize a program 
of grants and contracts for the development of drugs 
for rare diseases and conditions (commonly referred to 
as ‘‘orphan drugs’’). 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
22:00 May 03, 2022
H7640
2 
•HR 7640 IH
SECTION 1. REAUTHORIZATION OF GRANTS AND CON-
1
TRACTS FOR DEVELOPMENT OF ORPHAN 
2
DRUGS. 
3
Section 5(c) of the Orphan Drug Act (21 U.S.C. 
4
360ee(c)) is amended by striking ‘‘2018 through 2022’’ 
5
and inserting ‘‘2023 through 2027’’. 
6
Æ 
22:00 May 03, 2022
H7640
